CLRB
Cellectar Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.14
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-74.7%
Return on equity
-60.9%
Return on assets
-74.9%
Return on invested capital
0.00x
Asset turnover
-$19.5M
Cash from operations
$3.60
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026